QQ客服 官方微博 反馈留言

	A Multicenter, Open-Label, Randomized Phase II Controlled Study of rh-Endostatin (Endostar) in Combination with Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer
	Lu, Shun; Li, Lu; Luo, Yi; Zhang, Li; Wu, Gang; Chen, Zhiwei; Huang, Cheng; Guo, Shuliang; Zhang, Yiping; Song, Xiangqun
刊名	JOURNAL OF THORACIC ONCOLOGY
	2015
卷号	10期号:1
关键词	Etoposide Carboplatin Rh-endostatin Extensive-stage small-cell lung cancer Survival
ISSN号	1556-0864
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3543278
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Lu, Shun,Li, Lu,Luo, Yi,et al. A Multicenter, Open-Label, Randomized Phase II Controlled Study of rh-Endostatin (Endostar) in Combination with Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer[J]. JOURNAL OF THORACIC ONCOLOGY,2015,10(1).
APA	Lu, Shun.,Li, Lu.,Luo, Yi.,Zhang, Li.,Wu, Gang.,...&Hu, Chengping.(2015).A Multicenter, Open-Label, Randomized Phase II Controlled Study of rh-Endostatin (Endostar) in Combination with Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer.JOURNAL OF THORACIC ONCOLOGY,10(1).
MLA	Lu, Shun,et al."A Multicenter, Open-Label, Randomized Phase II Controlled Study of rh-Endostatin (Endostar) in Combination with Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer".JOURNAL OF THORACIC ONCOLOGY 10.1(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。